$3.27 Billion Forecast for Point-of-Care (POC) Coagulation Testing Devices Market by 2029, Backed by Demand and Innovation
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Point-of-Care (POC) Coagulation Testing Devices Market’s Growth Trajectory From 2025 To 2034?
The market size of point-of-care (poc) coagulation testing devices has demonstrated robust growth over the recent years. The market value is projected to escalate from $2.12 billion in 2024 to $2.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. Factors contributing to the historical growth include the rising incidence of infectious and chronic diseases, expanding elderly population, more frequent use of compact portable devices, increased adoption of biomarker profiling, in addition to an elevated demand for personalized medicine.
The market size for point-of-care (poc) coagulation testing devices is forecasted to experience robust growth in the upcoming years, expanding to $3.27 billion by 2029, with an annual growth rate (CAGR) of 9.0%. This surge during the prediction period can be ascribed to an increased requirement for swift and precise disease diagnosis, a rising focus on wellness and proactive healthcare, escalating demand for speedy and on-site diagnostic testing, a surge in outbreaks of infectious diseases, and the emergence of telemedicine. Key trends to watch for in this forecast period incorporate the integration of next-generation sequencing (NGS), RNA detection and analysis, single-cell PCR analysis, tools for bioinformatics software and data analysis, the advent of microfluidic technologies, lab-on-a-chip systems, point-of-care testing (POCT), artificial intelligence (AI) and data analytics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
What Are the Core Market Drivers Propelling Growth in the Point-of-Care (POC) Coagulation Testing Devices Industry?
The escalating occurrence of disorders that hinder the blood’s capacity to clot appropriately is anticipated to boost the expansion of the point-of-care (POC) coagulation testing devices market in the future. Certain lifestyle choices, such as smoking, drinking alcohol excessively, and inactive living, can lead to clotting disorders as they can impact the health of the blood vessels, clotting factor levels, and blood circulation, thereby enhancing the likelihood of anomalous clot formation. POC coagulation testing devices allow medical practitioners to instantly evaluate a patient’s coagulation state, enabling swift modifications to drug doses and treatment strategies. The World Federation of Hemophilia, a Canadian international non-profit organization, revealed in their annual global report in October 2023 that 427,685 individuals suffered from bleeding afflictions in 2022. This encompasses 257,146 individuals with hemophilia, including 208,957 with Hemophilia A, 42,203 with Hemophilia B, and 5,986 with an undetermined type of hemophilia. An additional 70,034 individuals suffer from other forms of bleeding disorders. Hence, the escalating occurrence of clotting disorders primarily fuels the expansion of point-of-care (POC) coagulation testing devices market.
How Is the Point-of-Care (POC) Coagulation Testing Devices Market Segmented?
The point-of-care (poc) coagulation testing devicesmarket covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp
Which Regions Are Driving the Next Phase of the Point-of-Care (POC) Coagulation Testing Devices Market Growth?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Point-of-Care (POC) Coagulation Testing Devices Industry?
Prominent organizations in the point-of-care (POC) coagulation testing devices market are advancing in the creation of immunofluorescence-based quantitative analyzers, aimed to enhance diagnosis and management of coagulation disorders. These analyzers are diagnostic tools in laboratories that ascertain and measure specific proteins or molecules that play a role in coagulation, contributing to diagnosis and management of blood clotting disorders. For example, in January 2023, Cipla Limited, a pharmaceutical company from India, introduced Cippoint. This is an immunofluorescence-based quantitative analyzer that takes advantage of immunofluorescence technology to offer fast and correct test results within a span of 3 to 15 minutes, promoting quicker clinical judgment processes. Cippoint’s accessible interface, prompt results, and broad testing capabilities are pivotal in improving diagnostic effectiveness, allowing for timely clinical decisions, and enhancing patient care outcomes.
View the full report here:
How Is the Point-of-Care (POC) Coagulation Testing Devices Market Defined and What Are Its Core Parameters?
Point-of-care (POC) coagulation testing devices are portable, easy-to-use medical devices used to assess the clotting ability of blood outside of a traditional laboratory setting. They are designed to provide rapid and accurate results, allowing healthcare providers to make immediate treatment decisions for patients with coagulation disorders or those at risk of abnormal bleeding or clotting.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15636
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
